Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?

Endogenous versus exogenous cell replacement for Parkinson’s disease: where are we at and where are we going?

Parkinson’s disease is the second most common neurodegenerative disease and has currently no effective treatment, one that would be able to stop or reverse the loss of dopaminergic neurons in the substantia nigra pars compacta. In addition, Parkinson’s disease diagnosis is typically done when a sign...

Full description

Bibliographic Details
Main Authors: Theodora Mourtzi, Ilias Kazanis
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Neural Regeneration Research
Subjects:
endogenous; neurodegenerative disease; neurogenesis; neurotrophic factors; parkinson’s disease; stem cells; transdifferentiation; transplantations
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=12;spage=2637;epage=2642;aulast=Mourtzi

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2022;volume=17;issue=12;spage=2637;epage=2642;aulast=Mourtzi

Similar Items